Lumateperone in the Treatment of Stuttering, Childhood Onset Fluency Disorder
Lumateperone in the Treatment of Stuttering, Childhood Onset Fluency Disorder
Recruiting · NCT07734103 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lumateperone in the Treatment of Stuttering, Childhood Onset Fluency Disorder | Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Stuttering, Stuttering, Adult, communication disorder, language disorder, nervous system disorder, speech disorder | Recruiting | Phase 2 | 2026-07-29 | NCT07734103 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CSTrials Inc. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CSTrials | Costa Mesa | United States | 1 |